This compound is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of various active pharmaceutical ingredients (APIs). It is particularly significant in the development of drugs targeting neurological and psychiatric disorders, such as antidepressants and antipsychotics. Its chiral structure allows for the creation of enantiomerically pure compounds, which can enhance drug efficacy and reduce side effects. Additionally, it may be employed in research settings to study receptor interactions and develop novel therapeutic agents. Its specific functional groups, including the fluorine and methoxy groups on the phenyl ring, make it a versatile building block for complex organic synthesis in medicinal chemistry, enabling targeted receptor binding.